It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cerium oxide nanoparticles possess unique properties that make them promising candidates in various fields, including cancer treatment. Among the proposed synthesis methods for CNPs, biosynthesis using natural extracts, offers an eco-friendly and convenient approach for producing CNPs, particularly for biomedical applications. In this study, a novel method of biosynthesis using the aqueous extract of Eucalyptus camaldulensis leaves was used to synthesize CNPs. Scanning electron microscopy and Transmission electron microscopy (TEM) techniques revealed that the synthesized CNPs exhibit a flower-like morphology. The particle size of CNPs obtained using Powder X-ray diffraction peaks and TEM as 13.43 and 39.25 nm. Energy-dispersive X-ray spectroscopy and Fourier transform infrared spectroscopy confirmed the effect of biomolecules during the synthesis process and the formation of CNPs. The cytotoxicity of biosynthesized samples was evaluated using the MTT method demonstrating the potential of these samples to inhibit MCF-7 cancerous cells. The viability of the MCF-7 cell line conducted by live/dead imaging assay confirmed the MTT cytotoxicity method and indicated their potential to inhibit cancerous cells. Furthermore, the successful uptake of CNPs by MCF-7 cancer cells, as demonstrated by confocal microscopy, provides evidence that the intracellular pathway contributes to the anticancer activity of the CNPs. In general, results indicate that the biosynthesized CNPs exhibit significant cytotoxicity against the MCF-7 cancerous cell line, attributed to their high surface area.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of South Africa, Muckleneuk Ridge, UNESCO-UNISA-iTLABS Africa Chair in Nanoscience and Nanotechnology, College of Graduate Studies, Pretoria, South Africa (GRID:grid.412801.e) (ISNI:0000 0004 0610 3238); University of Tehran, School of Chemistry, College of Science, Tehran, Iran (GRID:grid.46072.37) (ISNI:0000 0004 0612 7950)
2 University of South Africa, Muckleneuk Ridge, UNESCO-UNISA-iTLABS Africa Chair in Nanoscience and Nanotechnology, College of Graduate Studies, Pretoria, South Africa (GRID:grid.412801.e) (ISNI:0000 0004 0610 3238)
3 Bio Organic, University of Tehran, Neuroscience Laboratory, Institute of Biochemistry and Biophysics (IBB), Tehran, Iran (GRID:grid.46072.37) (ISNI:0000 0004 0612 7950)
4 Sharif University of Technology, Department of Chemistry, Tehran, Iran (GRID:grid.412553.4) (ISNI:0000 0001 0740 9747)
5 University of the Western Cape, School of Pharmacy, Bellville, South Africa (GRID:grid.8974.2) (ISNI:0000 0001 2156 8226)
6 University of Tehran, School of Chemistry, College of Science, Tehran, Iran (GRID:grid.46072.37) (ISNI:0000 0004 0612 7950)